T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1

Immunogenetics

Volumn 57, Issue 1-2, 2005, Pages 8-15

  Stepniak, Dariusz ^a   Vader, L Willemijn ^a   Kooy, Yvonne ^a   Van Veelen, Peter A ^b   Moustakas, Antonis ^c   Papandreou, Nikolaos A ^d   Eliopoulos, Elias ^d   Drijfhout, Jan Wouter ^a   Papadopoulos, George K ^c   Koning, Frits ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c Faculty of Agricultural Technology   (Greece)

^d AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Celiac disease; Gluten epitope; HLA DQ2

Indexed keywords

GLIADIN; GLUTEN; GLUTENIN; HLA DQ2 ANTIGEN; PEPTIDE DERIVATIVE; POLYPEPTIDE; PROLINE; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MOLECULAR MODEL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SEQUENCE; COMPUTER SIMULATION; DATABASES, PROTEIN; EPITOPES, T-LYMPHOCYTE; GLUTEN; HLA-DQ ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROLINE; T-LYMPHOCYTES;

EID: 20944439074     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-005-0780-8     Document Type: Article

References (25)

1. Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN (2000) The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191:603-612
2. Arentz-Hansen H, McAdam SN, Molberg O, Fleckenstein B, Lundin KE, Jorgensen TJ, Jung G, Roepstorff P, Sollid LM (2002) Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 123:803-809
3. Arnold PY, La Gruta NL, Miller T, Vignali KM, Adams PS, Woodland DL, Vignali DA (2002) The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues. J Immunol 169:739-749
4. De Oliveira DB, Harfouch-Hammoud E, Otto H, Papandreou NA, Stern LJ, Cohen H, Boehm BO, Bach J, Caillat-Zucman S, Walk T, Jung G, Eliopoulos E, Papadopoulos GK, van Endert PM (2000) Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition. Mol Immunol 37:813-825
5. Hennecke J, Wiley DC (2002) Structure of a complex of the human alpha/beta T cell receptor (TCR) HA 1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J Exp Med 195:571-581
6. Hennecke J, Carfi A, Wiley DC (2000) Structure of a covalently stabilized complex of a human alpha/beta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J 19:5611-5624
7. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1996) Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc Natl Acad Sci USA 93:734-738
8. Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM (2004) Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 101:4175-4179
9. Koelle DM, Johnson ML, Ekstrom AN, Byers P, Kwok WW (1997) Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/ DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201. Hum Immunol 53:195-205
10. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713-717
11. Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM (2001 ) T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol 31:1317-1323
12. Moudgil KD, Sercarz EE, Grewal IS (1998) Modulation of the immunogenicity of antigenic determinants by their flanking residues. Immunol Today 19:217-220
13. Reichstetter S, Papadopoulos GK, Moustakas AK, Swanson E, Liu AW, Beheray S, Ettinger RA, Nepom GT, Kwok WW (2002) Mutational analysis of critical residues determining antigen presentation and activation of HLA-DQ0602 restricted T-cell clones. Hum Immunol 63:185-193
14. Rudolph MG, Wilson IA (2002) The specificity of TCR/pMHC interaction. Curr Opin Immunol 14:52-65
15. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E (1989) Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169:345-350
16. Vader LW, De Ru A, van der Wal Y, Kooy YM, Benckhuijsen W, Mearin ML, Drijfhout JW, van Veelen P, Koning F (2002a) Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 195:643-649
17. Vader W, Kooy Y, van Veelen P, De Ru A, Hams D, Benckhuijsen W, Pena S, Mearin L, Drijfhout JW, Koning F (2002b) The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122:1729-37
18. Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, Spaenij L, Koning F (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 100:12390-12395
19. Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanovic S, Eriksen JE, Sletten K, Thorsby E, Rammensee HG, Sollid LM (1996) The peptide binding motif of the disease associated HLA-DQ (alpha 1*0501, beta 1*0201) molecule. Eur J Immunol 26:2764-2772
20. Wal Y van de, Kooy YMC, Drijfhout JW, Amons R, Koning F (1996) Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics 44:246-253
21. Wal Y van de, Kooy YM, Drijfhout JW, Amons R, Papadopoulos GK, Koning F (1997) Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. Immunogenetics 46:484-492
22. Wal Y van de, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G, Koning F (1998a) Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161:1585-1588
23. Wal Y van de, Kooy YM, van Veelen PA, Pena SA, Mearin LM, Molberg O, Lundin KE, Sollid LM, Mutis T, Benckhuijsen WE, Drijfhout JW, Koning F (1998b) Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 95:10050-4
24. Wieser H, Seilmeier W, Belitz HD (1980) Comparative investigations of partial amino acid sequences of prolamines and glutelins from cereals. II. Fractionation of glutelins (Author's translation). Z Lebensm Unters Forsch 171:430-436
25. Yassai M, Afsari A, Garlie J, Gorski J (2002) C-terminal anchoring of a peptide to class II MHC via the P10 residue is compatible with a peptide bulge. J Immunol 168:1281-1285